weight loss medicines

Product Name: Noveltreat Semaglutide 2.4 mg/0.75 mL Prefilled Pen Category: Weight Management & GLP-1 Medicines Supplier Enquiries: BizHQ – Medicine India Export Product Overview Noveltreat Semaglutide 2.4 mg is a semaglutide solution for subcutaneous injection, presented in a single-dose prefilled pen. BizHQ – Medicine India Export welcomes sourcing enquiries from licensed pharmaceutical importers, distributors, wholesalers, and healthcare procurement businesses worldwide. Product availability, manufacturer authorization, and destination-country regulatory eligibility must be confirmed before quotation or shipment. Product Specifications Parameter Details Brand Name Noveltreat Generic Name Semaglutide Strength 2.4 mg/0.75 mL Dosage Form Injection Solution Administration Subcutaneous Packaging 2 Single-Dose Prefilled Pens Therapeutic Class GLP-1 Receptor Agonist Manufacturer To be verified Country of Export India, subject to authorization Storage As per verified manufacturer labeling MOQ On Enquiry Wholesale Price Request Quotation Supply Status Subject to verification Specifications are based on the supplied product packaging. Product Information Semaglutide is a GLP-1 receptor agonist used in certain authorized medicines for chronic weight management and other approved indications. The 2.4 mg strength is used as a maintenance dose in some approved semaglutide treatment regimens. The specific indications, dosing instructions, contraindications, and precautions for Noveltreat must be verified against its approved prescribing information. This product is intended for prescription-based, regulated pharmaceutical distribution. Target Export Markets Middle East: UAE, Saudi Arabia, Qatar, Kuwait, Oman, Bahrain Africa: South Africa, Nigeria, Kenya, Ghana, Tanzania, Uganda, Zambia Europe: United Kingdom, Germany, France, Italy, Spain, Netherlands North America: USA, Canada Asia-Pacific: Australia, New Zealand, Singapore, Malaysia, Philippines, Thailand, Vietnam Latin America: Brazil, Mexico, Colombia, Chile, Peru These countries are target markets for licensed B2B enquiries, not confirmed approved export destinations. Importation is subject to product registration, local regulatory approvals, licensing, and other applicable requirements. International Wholesale & Export Enquiries Licensed pharmaceutical buyers may contact BizHQ to discuss: Product and batch documentation Manufacturer authorization and product authenticity Minimum order quantity and commercial quotations Destination-country import eligibility Pharmaceutical cold-chain logistics Packaging and shipment requirements Frequently Asked Questions 1. Is Noveltreat Semaglutide 2.4 mg available for bulk orders? Bulk supply availability must be confirmed with BizHQ, together with manufacturer authorization and regulatory eligibility. 2. What is the MOQ for Noveltreat Semaglutide injection? Minimum order quantity depends on verified availability and commercial terms. Contact BizHQ for details. 3. Can Noveltreat be exported to UAE, UK, USA, or Nigeria? Export is possible only where the exact product satisfies applicable import, marketing authorization, and distribution requirements. 4. What is the wholesale price of Noveltreat Semaglutide 2.4 mg? Pricing is available on enquiry, subject to product availability and a compliant transaction. 5. What documents are required for importing this injection? Requirements may include an import license, product registration, commercial invoice, COA, GMP evidence, and relevant shipping documentation. 6. Does Noveltreat require cold-chain shipping? The product must be transported under the temperature conditions specified in its verified manufacturer labeling. 7. How can international distributors request a quotation? Provide your company name, country, pharmaceutical license details, required quantity, and delivery destination. Request a Wholesale Quotation BizHQ – Medicine India Export 🌐 Website: https://www.medicineindiaexport.com/ 📧 Email: sales.medindiaexport@gmail.com 📱 WhatsApp: +91 7218129896 Product Enquiry: Noveltreat Semaglutide 2.4 mg/0.75 mL Prefilled Pen

Product Category: GLP-1 Receptor Agonist Product Name: Noveltreat 1.7 mg Generic Name: Semaglutide Dosage Form: Solution for Injection Strength: 1.7 mg Packaging: Prefilled Injection Pen Administration: Subcutaneous Supplier Enquiries: Medicine India Export Product Overview Noveltreat Semaglutide 1.7 mg is presented as a prefilled injection pen containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide is used in certain authorized prescription medicines for chronic weight management and type 2 diabetes. Approved indications, dosing schedules, and eligibility differ by product and jurisdiction. Medicine India Export welcomes enquiries from licensed pharmaceutical wholesalers, distributors, importers, and healthcare procurement organizations seeking product specifications and regulatory documentation. Product Specifications Specification Details Brand Name Noveltreat Generic Name Semaglutide Strength 1.7 mg Dosage Form Injectable Solution Delivery System Prefilled Pen Route Subcutaneous Injection Product Classification Prescription Pharmaceutical Product Type GLP-1 Receptor Agonist Manufacturer To be verified Storage Conditions Refer to manufacturer-approved labeling Minimum Order Quantity On Enquiry Export Eligibility Subject to destination-country authorization International Wholesale Enquiries Medicine India Export accepts regulatory and commercial enquiries concerning pharmaceutical sourcing for international markets. Target Markets – Group 1 United States, United Kingdom, United Arab Emirates, Saudi Arabia. Target Markets – Group 2 Australia, South Africa, Kenya. These are target markets for buyer enquiries only. Availability, product registration, and lawful importation of Noveltreat must be verified separately for each destination. Quality Assurance and Documentation Licensed pharmaceutical buyers may request information regarding: Manufacturing licenses and GMP documentation Product registration and marketing authorization Batch-specific Certificate of Analysis Product specifications and packaging Shelf life and manufacturer-approved storage conditions Cold-chain transportation requirements Export and import documentation Documentation availability is subject to verification with the relevant manufacturer and supplier. Frequently Asked Questions What is Noveltreat Semaglutide 1.7 mg? Noveltreat is the brand name displayed on the referenced packaging for a semaglutide 1.7 mg prefilled injection product. Its regulatory authorization and manufacturer information should be independently confirmed. Is Noveltreat available for international wholesale orders? Buyers should contact Medicine India Export to enquire about sourcing possibilities. Product availability and authorization for specific markets have not been established. Can Noveltreat be imported into the USA or UK? Import eligibility depends on the exact product's regulatory status and applicable national laws. Authorization of another semaglutide medicine does not authorize Noveltreat. What is the MOQ for Semaglutide 1.7 mg injection? Minimum order quantities and commercial terms can be requested from the supplier. Does semaglutide injection require cold-chain shipping? Storage and transportation must follow the exact product's approved manufacturer instructions. Refrigeration requirements should be verified before shipment. How can international buyers request product documentation? Licensed importers and distributors can contact Medicine India Export by email or WhatsApp with their company details, destination country, and requested quantity. Request a Wholesale Quotation Medicine India Export Website: https://www.medicineindiaexport.com/ Email: sales.medindiaexport@gmail.com WhatsApp: +91 7218129896

Noveltreat Semaglutide Solution for Injection is a prescription injectable pharmaceutical containing semaglutide, a GLP-1 receptor agonist. The product is supplied in a pre-filled pen format and is intended for use under qualified medical supervision. Product Details Specification Details Product Name Noveltreat Semaglutide Solution for Injection Active Ingredient Semaglutide Strength 1 mg Dosage Form Solution for Injection Presentation Pre-filled Injection Pen Therapeutic Class GLP-1 Receptor Agonist Route Subcutaneous Prescription Status Prescription Medicine Brand Noveltreat Uses Semaglutide is used for approved medical indications such as type 2 diabetes management and, depending on the specific formulation and regulatory approval, chronic weight management. Treatment should be initiated and monitored by a qualified healthcare professional. Key Benefits Convenient pre-filled pen presentation Contains semaglutide as the active pharmaceutical ingredient Designed for subcutaneous administration Suitable for prescription-based pharmaceutical use Convenient format for appropriate patients under medical supervision Safety & Precautions Semaglutide should be used strictly according to the prescribing information provided with the product. Possible adverse effects may include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. Patients should inform their healthcare professional about existing medical conditions and other medicines they are taking before starting treatment. Do not use or change the dosage without professional medical advice. Storage Store and handle the product according to the manufacturer's approved storage instructions printed on the packaging. Appropriate temperature-controlled handling may be required. International Pharmaceutical Supply MEDINDIA EXPORT provides pharmaceutical export and sourcing assistance for eligible international buyers. Availability, export documentation, shipping arrangements, import permissions, and regulatory requirements depend on the destination country. We support inquiries from international markets including: USA | UK | Singapore | Thailand | UAE | Australia | Malaysia | New Zealand | Canada | Europe | Middle East | Asia-Pacific Trading FAQs Q. What is Noveltreat Semaglutide Injection? Noveltreat is a semaglutide-containing injectable prescription medicine supplied in a pre-filled pen. Q. What is the active ingredient? The active ingredient is semaglutide. Q. How is it administered? It is intended for subcutaneous administration, according to the healthcare professional's instructions. Q. Can you supply this product internationally? International supply is subject to product availability, applicable export regulations, and the import requirements of the destination country. Q. Can I order without a prescription? Semaglutide is a prescription medicine. Customers should comply with the prescription and pharmaceutical-import requirements applicable in their country. Q. How can I request a quotation? Contact our sales team with the product name, required quantity, destination country, and relevant business/import details. Request a Quote 🌐 Website: www.medicineindiaexport.com 📧 Email: sales.medindiaexport@gmail.com 📱 WhatsApp: +91 7218129896

Product Name: Noveltreat™ Semaglutide Solution for Injection Active Ingredient: Semaglutide Strength: 0.25 mg Dosage Form: Solution for Injection Presentation: Prefilled Pen Pack Size: 2 Single-Dose Prefilled Pens Volume: 0.5 mL per pen Route of Administration: Subcutaneous Therapeutic Category: GLP-1 Receptor Agonist Product Description Noveltreat™ Semaglutide Solution for Injection 0.25 mg is a semaglutide-based injectable pharmaceutical product supplied in a prefilled-pen format. The product is intended for use under the supervision of a qualified healthcare professional and according to the approved prescribing information applicable in the destination market. The 0.25 mg strength may be used as part of an initial treatment regimen where specifically indicated by the relevant product information. Key Product Features Semaglutide-based injectable formulation 0.25 mg strength Convenient prefilled-pen presentation Single-dose pen format Subcutaneous administration Suitable for pharmaceutical sourcing and export inquiries, subject to applicable regulations Commonly Associated Therapeutic Uses Semaglutide products may be approved for specific diabetes and/or weight-management indications depending on the product and country. Always verify the approved indication for the exact product in the destination country before use or distribution. Storage & Handling Store and handle the product strictly according to the manufacturer's official packaging and prescribing information. Temperature requirements can be important for injectable medicines, particularly during pharmaceutical transportation. International Pharmaceutical Export MEDINDIA EXPORT provides international medicine-export and pharmaceutical sourcing support for eligible destinations. International orders may be subject to: Import regulations Prescription requirements Product registration Customs clearance Import permits Destination-country pharmaceutical laws Cold-chain or transportation requirements where applicable Availability and export eligibility should be confirmed before ordering. Trading FAQs Q1. What is Noveltreat Semaglutide 0.25 mg? Noveltreat is a semaglutide-containing injectable product supplied in a 0.25 mg prefilled-pen presentation. Q2. What is the pack size? The displayed presentation contains 2 single-dose prefilled pens, each indicated as 0.25 mg/0.5 mL. Q3. How is the product administered? It is intended for subcutaneous administration according to the applicable prescribing information. Q4. Is Noveltreat available for international export? Export availability depends on destination-country regulations, product availability and required import permissions. Q5. Can I purchase this product for resale? Commercial distribution must comply with the pharmaceutical and import regulations applicable in the destination market. Q6. Does MEDINDIA EXPORT support international buyers? Yes. We accept pharmaceutical sourcing and export inquiries for eligible international destinations. Request a Catalogue / Trade Inquiry For Noveltreat™ Semaglutide 0.25 mg availability, pricing, packing details and international trade inquiries, contact: 🌐 Website: www.medicineindiaexport.com 📧 Email: sales.medindiaexport@gmail.com 📱 WhatsApp: +91 7218129896 MEDINDIA EXPORT – International Medicine Export & Pharmaceutical Sourcing

Product Name: Noveltreat 0.5 mg Generic Name: Semaglutide Dosage Form: Solution for Injection Strength: 0.5 mg/0.5 mL Pack Size: 2 Single-Dose Prefilled Pens Route of Administration: Subcutaneous Product Category: Specialty Pharmaceutical / Metabolic & Endocrine Medicines Prescription Status: Prescription medicine Product Description Noveltreat 0.5 mg contains semaglutide in a prefilled pen presentation for subcutaneous administration. Semaglutide belongs to the GLP-1 receptor agonist class and is used for approved indications according to the applicable prescribing information in each market. This product is available for legitimate pharmaceutical sourcing and international trade inquiries, subject to destination-country regulations, product authorization, import requirements, and applicable documentation. Key Features Semaglutide injection 0.5 mg/0.5 mL presentation Single-dose prefilled pen Pack contains 2 prefilled pens Suitable for pharmaceutical B2B sourcing inquiries International export support available for eligible markets Therapeutic Category Metabolic & Endocrine / GLP-1 Receptor Agonist Semaglutide products may have different approved indications depending on the specific brand, formulation, strength, and country. Buyers should refer to the locally approved product information. International Export Markets MEDINDIA EXPORT handles pharmaceutical export inquiries for multiple international destinations, including: USA | UK | Singapore | Thailand | UAE | Australia | Malaysia | New Zealand Importers should verify local registration, prescription, import licensing, customs, storage, and distribution requirements before ordering. Packaging Information Presentation: Prefilled pen Strength: 0.5 mg/0.5 mL Pack: 2 single-dose prefilled pens Administration: Subcutaneous use only Storage & Handling Storage and transportation should follow the manufacturer's approved product information and applicable cold-chain requirements. Importers and distributors are responsible for ensuring appropriate pharmaceutical handling throughout transportation and storage. Important Safety Information Semaglutide is a prescription medicine and should be used only according to appropriate medical advice and the approved product information. Potential adverse effects can include gastrointestinal symptoms. Patients should consult a qualified healthcare professional before use. Do not purchase, distribute, or import this medicine where it is not legally authorized. B2B Pharmaceutical Export Inquiry For wholesale, distributor, pharmacy, institutional, or other legitimate pharmaceutical trade inquiries, please provide: Destination country Required quantity Company/importer details Required packaging Any applicable import documentation Contact MEDINDIA EXPORT 🌐 Website: www.medicineindiaexport.com 📧 Email: sales.medindiaexport@gmail.com 📱 WhatsApp: +91 7218129896 MEDINDIA EXPORT – International Pharmaceutical Sourcing & Export Support

Product Name: Insulin Lispro Injection 100 Units/mL (U-100) – Prefilled KwikPen Active Ingredient: Insulin Lispro Dosage Form: Injectable solution Strength: 100 Units/mL Presentation: 3 mL prefilled pen Category: Diabetes / Antidiabetic / Insulin Insulin Lispro is a rapid-acting insulin analogue used to improve blood-glucose control in people with diabetes who require insulin therapy. Official prescribing information describes U-100 insulin lispro as a rapid-acting insulin and provides administration and storage requirements. Product Overview Insulin Lispro 100 Units/mL is supplied in a prefilled pen presentation designed for subcutaneous insulin administration. The U-100 KwikPen presentation contains 3 mL (300 units) of insulin lispro. The product shown in the supplied image is a Humalog/insulin lispro KwikPen-style presentation. Product branding, packaging, registration status and availability can differ between countries. Uses of Insulin Lispro Insulin lispro may be prescribed for: Diabetes mellitus requiring insulin therapy Improvement of blood-glucose control Mealtime insulin management as part of an individualized diabetes treatment plan The exact dose and timing should be determined by the treating healthcare professional based on the patient's glucose levels, diet, insulin regimen and other clinical factors. Important Safety Considerations Insulin can cause hypoglycemia (low blood glucose) if the amount administered is greater than required. Patients should follow their prescribed insulin regimen and glucose-monitoring instructions. The KwikPen should not be shared between patients, even when the needle is changed. Insulin storage is also important. Unopened U-100 insulin lispro is generally refrigerated at 2°C–8°C (36°F–46°F) and should not be frozen, subject to the specific product's approved labeling. International Medicine Trading & Export Insulin products are temperature-sensitive pharmaceutical products, so international trading requires appropriate packaging, storage and transportation procedures. Import requirements, prescription rules, product registration, cold-chain requirements and customs documentation vary by destination. Target export markets: 🇺🇸 USA 🇬🇧 UK 🇸🇬 Singapore 🇹🇭 Thailand 🇦🇪 UAE 🇦🇺 Australia 🇲🇾 Malaysia 🇳🇿 New Zealand 🌍 Other international destinations, subject to applicable regulations For international orders, buyers should verify the medicine's legality, registration/import requirements and prescription requirements in their destination country before placing an order. Trading FAQs 1. What is Insulin Lispro? Insulin lispro is a rapid-acting insulin analogue used for blood-glucose management in patients requiring insulin therapy. 2. What strength is this product? The product shown is Insulin Lispro 100 Units/mL (U-100). 3. What is the KwikPen volume? The U-100 KwikPen presentation is a 3 mL prefilled pen containing 300 units. 4. Is Insulin Lispro prescription medicine? Yes. Insulin therapy should be used according to a healthcare professional's prescription and instructions. 5. Can the pen be shared? No. A KwikPen is intended for use by a single patient and should never be shared. 6. How should insulin be shipped internationally? Because insulin is temperature-sensitive, appropriate temperature-controlled handling and packaging should be arranged according to the manufacturer's requirements and applicable transport regulations. 7. Can you export Insulin Lispro worldwide? Availability depends on the destination country's pharmaceutical import, prescription, registration and customs requirements. Orders should be evaluated according to the regulations applicable to the destination. 8. Do you provide international medicine supply? MEDINDIA EXPORT / BizHQ can assist with international pharmaceutical supply inquiries, subject to product availability and destination-country regulations. Why Contact MEDINDIA EXPORT? We provide pharmaceutical export and international medicine supply assistance for customers and trading partners across multiple international markets. 🌐 Website: www.medicineindiaexport.com 📧 Email: sales.medindiaexport@gmail.com 📱 WhatsApp: +91 7218129896

Product Name: Mounjaro 15 mg KwikPen Active Ingredient: Tirzepatide Strength: 15 mg per dose Dosage Form: Injectable solution Device: Pre-filled KwikPen Pack Size: 4 doses per pen Route: Subcutaneous injection Manufacturer: Eli Lilly Prescription Status: Prescription medicine Product Overview Mounjaro 15 mg KwikPen contains tirzepatide, a GIP and GLP-1 receptor agonist. It is used under medical supervision for approved indications, which vary according to the destination country's regulatory approval. Key Features 15 mg tirzepatide per dose Multi-dose pre-filled KwikPen Four doses per pen Designed for once-weekly administration as prescribed Convenient pen-delivery format Storage Store according to the approved local product information. Refrigerated storage at 2–8°C is generally specified, and the product should not be frozen. 📞 Contact & Export Enquiries 🌐 Website: www.medicineindiaexport.com 📧 Email: sales.medindiaexport@gmail.com 📱 WhatsApp: +91 [Your WhatsApp Number]

Product Name: Mounjaro 12.5 mg KwikPen Active Ingredient: Tirzepatide Strength: 12.5 mg per dose Dosage Form: Injectable solution Device: Pre-filled KwikPen Pack Size: 4 weekly doses per pen Route: Subcutaneous injection Manufacturer: Eli Lilly Prescription: Prescription medicine Product Overview Mounjaro 12.5 mg KwikPen contains tirzepatide, a GIP and GLP-1 receptor agonist. It is used under medical supervision for approved indications, which vary by country. Key Features 12.5 mg tirzepatide per dose Multi-dose pre-filled pen Designed for once-weekly administration as prescribed Convenient pen delivery system Suitable storage and handling should follow the approved local product information. Storage Store refrigerated at 2–8°C and protect from freezing. Follow the manufacturer's/local regulatory storage instructions. 📞 Contact & Enquiries 🌐 Website: www.medicineindiaexport.com 📧 Email: sales.medindiaexport@gmail.com 📱 WhatsApp: +91 [Your WhatsApp Number] For: Product availability • Export enquiries • Bulk orders • International shipping enquiries Prescription medicine. Availability, indications, packaging and export requirements may vary by destination country.

Brand Name: Mounjaro® Generic Name: Tirzepatide Strength: 7.5 mg Dosage Form: Injection Device: KwikPen Route: Subcutaneous Active Ingredient: Tirzepatide Dosing: Once weekly, as prescribed by a healthcare professional Prescription Status: Prescription medicine Product Description Mounjaro 7.5 mg KwikPen contains tirzepatide and is supplied in a multi-dose prefilled KwikPen presentation for subcutaneous administration. Mounjaro is a prescription medicine used under the supervision of a qualified healthcare professional. Key Features Tirzepatide 7.5 mg strength Prefilled KwikPen presentation Subcutaneous administration Once-weekly use as prescribed Prescription-only medicine Professional pharmaceutical supply and export support Storage Store according to the manufacturer's specified storage conditions. Protect the product from inappropriate temperatures, direct sunlight, and moisture. Keep out of reach of children. Follow the product-specific storage instructions supplied with the medicine. Important Notice Mounjaro is a prescription medicine. Use only under the direction of a qualified healthcare professional. Product availability, labeling, indications, packaging, and import requirements may vary by country. Buyers should verify applicable local regulations before ordering or importing. MEDINDIA EXPORT Pharmaceutical Exporter & Supplier 🌐 Website: www.medicineindiaexport.com 📧 Email: sales.medindiaexport@gmail.com 📱 WhatsApp: +91 7218129896 📍 Location: Nagpur, Maharashtra, India For Product Enquiries Contact MEDINDIA EXPORT for product availability, quotation, packaging information, shipping options, and export documentation. Worldwide Pharmaceutical Supply | Wholesale & Export Enquiries

Brand Name: Mounjaro® Generic Name: Tirzepatide Strength: 5 mg Dosage Form: Injection Device: KwikPen Route: Subcutaneous Active Ingredient: Tirzepatide Dosing: Once weekly, as prescribed by a healthcare professional Prescription Status: Prescription medicine Product Description Mounjaro 5 mg KwikPen contains tirzepatide and is supplied in a prefilled KwikPen presentation designed for subcutaneous administration. Mounjaro is a prescription medicine used under the supervision of a qualified healthcare professional. Key Features Tirzepatide 5 mg strength Prefilled KwikPen presentation Subcutaneous administration Once-weekly use as prescribed Prescription-only medicine Professional pharmaceutical supply and export support Storage Store according to the manufacturer's specified storage conditions. Protect the product from inappropriate temperatures, direct sunlight, and moisture. Keep out of reach of children. Important Notice Mounjaro is a prescription medicine. Use only under the direction of a qualified healthcare professional. Product availability, labeling, indications, and import requirements may vary by country. Buyers should verify applicable local regulations before ordering or importing. MEDINDIA EXPORT Pharmaceutical Exporter & Supplier 🌐 Website: www.medicineindiaexport.com 📧 Email: sales.medindiaexport@gmail.com 📱 WhatsApp: +91 7218129896 📍 Location: Nagpur, Maharashtra, India For Product Enquiries Contact MEDINDIA EXPORT for product availability, quotation, packaging information, shipping options, and export documentation. Worldwide Pharmaceutical Supply | Wholesale & Export Enquiries

Brand Name: Mounjaro® Generic Name: Tirzepatide Strength: 2.5 mg Dosage Form: Injection Device: KwikPen Route: Subcutaneous Active Ingredient: Tirzepatide Dosing: Once weekly, as prescribed by a healthcare professional Prescription Status: Prescription medicine Product Description Mounjaro 2.5 mg KwikPen contains tirzepatide and is supplied in a convenient prefilled pen presentation. It is a prescription medicine used under the supervision of a qualified healthcare professional. Key Features Tirzepatide 2.5 mg strength Prefilled KwikPen presentation Convenient subcutaneous administration Suitable for prescription-based treatment Professional pharmaceutical export and supply support Storage Store according to the manufacturer's specified storage conditions. Protect the product from inappropriate temperatures, direct sunlight, and moisture. Keep out of reach of children. Important Notice Mounjaro is a prescription medicine. Use only under the direction of a qualified healthcare professional. Product availability, labeling, indications, and import requirements may vary by country. Buyers should verify applicable local regulations before ordering or importing. MEDINDIA EXPORT Pharmaceutical Exporter & Supplier 🌐 Website: www.medicineindiaexport.com 📧 Email: sales.medindiaexport@gmail.com 📱 WhatsApp: +91 7218129896 📍 Location: Nagpur, Maharashtra, India For Product Enquiries Contact MEDINDIA EXPORT for product availability, quotation, packaging information, shipping options, and export documentation. Worldwide Pharmaceutical Supply | Wholesale & Export Enquiries

Sembolic Semaglutide 14mg Tablet contains Semaglutide 14mg, an oral GLP-1 receptor agonist prescribed for the management of Type 2 Diabetes Mellitus in adults. It helps improve blood sugar control when used alongside a healthy diet and regular exercise. We export genuine Sembolic Semaglutide 14mg Tablets to licensed importers, wholesalers, pharmacies, hospitals, and distributors worldwide with secure packaging and competitive export pricing. Product Specifications Product Name: Sembolic Generic Name: Semaglutide Strength: 14 mg Dosage Form: Oral Tablet Category: Anti-Diabetic (GLP-1 Receptor Agonist) Packaging: As per manufacturer Country of Origin: India Features High-quality pharmaceutical product Export-quality packaging Bulk quantity available Worldwide shipping Competitive wholesale prices Reliable export documentation support Suitable for licensed importers and distributors Export Markets USA, Canada, United Kingdom, Australia, Singapore, UAE, Germany, France, Italy, New Zealand, Malaysia, South Africa, Netherlands, Saudi Arabia, Qatar, Oman, Kenya, Nigeria, and many more countries. Contact Us MEDINDIA EXPORT 🌐 Website: www.medicineindiaexport.com 📧 Email: sales.medindiaexport@gmail.com 📱 WhatsApp: +91 7218129896 Your Trusted Partner for Global Pharmaceutical Exports from India.